Resources Contact Us Home
Formulation of quinazoline based EGFR inhibitors containing a zinc binding moiety

Image Number 13 for United States Patent #8119616.

The present invention relates to a composition comprising an inclusion complex of a cyclodextrin and quinazoline containing zinc-binding moiety based derivatives. The cyclodextrin is preferable a .beta.-cyclodextrin or a derivative thereof. The quinazolines have enhanced and unexpected properties as inhibitors of epidermal growth factor receptor tyrosine kinase (EGFR-TK) and their use in the treatment of EGFR-TK related diseases and disorders such as cancer. The said derivatives may further act as HDAC inhibitors.

  Recently Added Patents
Antisense modulation of C-reactive protein expression
Backside structure and methods for BSI image sensors
Electric train drive control device
Alkaline battery
Feedback method and processing system for policy installation failures
Floor standing rack
  Randomly Featured Patents
AXMI-028 and AXMI-029, a family of novel delta-endotoxin genes and methods for their use
Compatible television system with companding of auxiliary signal encoding information
Preparation of polyvinyl halide with quaternary salt of cellulose sulfate
Vacuum sleeve valve
Expansion of fuel streams using mixed hydrocarbons
Mono- or polyenic carboxylic acid derivatives
Capo applicable to dobro and slide guitars, and other raised-string instruments
Plate for connecting elongated plates
Tool container
Window fog detecting apparatus